Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems
Abstract Background China has introduced a series of polices and practice to manage the market access of Chinese patent medicine (CPM) products into its healthcare security system, which is less analyzed and reported in current literature. Therefore, this paper aimed to investigate the mechanisms ma...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-01-01
|
| Series: | Chinese Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13020-021-00560-w |
| _version_ | 1819229119815090176 |
|---|---|
| author | Chenglai Xia Dongning Yao Yunfeng Lai Yan Xue Hao Hu |
| author_facet | Chenglai Xia Dongning Yao Yunfeng Lai Yan Xue Hao Hu |
| author_sort | Chenglai Xia |
| collection | DOAJ |
| description | Abstract Background China has introduced a series of polices and practice to manage the market access of Chinese patent medicine (CPM) products into its healthcare security system, which is less analyzed and reported in current literature. Therefore, this paper aimed to investigate the mechanisms managing market access of CPM products into healthcare security system in China, expecting to provide implications for international integration of traditional medicine products into health systems. Method This paper used a documentary analysis approach as a qualitative research method. Data were collected from four sources and analyzed in a thematic way. Results Four mechanisms to manage entry, price adjustment, and exit of innovative brand and generic CPM products are identified, including: (1) price negotiation, mechanism of new entry of innovative brand CPM products into the national reimbursement list; (2) price re-negotiation, mechanism of price adjustment of innovative brand CPM products within the national reimbursement list; (3) mass procurement, mechanism of generic CPM products to healthcare security system; and (4) direct removal, mechanism of removal from the national reimbursement list. Conclusions China has established market access framework of CPM products by focusing on price negotiation for innovative brand CPM products and mass procurement for generic CPM products. Further studies of CPM products based real-world data are needed to provide clinical and pharmacoeconomic evidence to support market access of CPM products into healthcare security systems. |
| first_indexed | 2024-12-23T11:08:07Z |
| format | Article |
| id | doaj.art-7b9d834ea4704377934abca3930960b6 |
| institution | Directory Open Access Journal |
| issn | 1749-8546 |
| language | English |
| last_indexed | 2024-12-23T11:08:07Z |
| publishDate | 2022-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Chinese Medicine |
| spelling | doaj.art-7b9d834ea4704377934abca3930960b62022-12-21T17:49:26ZengBMCChinese Medicine1749-85462022-01-011711710.1186/s13020-021-00560-wMarket access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systemsChenglai Xia0Dongning Yao1Yunfeng Lai2Yan Xue3Hao Hu4Southern Medical University Affiliated Maternal & Child Health Hospital of FoshanState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of MacauSchool of Public Health and Management, Guangzhou University of Chinese MedicineState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of MacauState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of MacauAbstract Background China has introduced a series of polices and practice to manage the market access of Chinese patent medicine (CPM) products into its healthcare security system, which is less analyzed and reported in current literature. Therefore, this paper aimed to investigate the mechanisms managing market access of CPM products into healthcare security system in China, expecting to provide implications for international integration of traditional medicine products into health systems. Method This paper used a documentary analysis approach as a qualitative research method. Data were collected from four sources and analyzed in a thematic way. Results Four mechanisms to manage entry, price adjustment, and exit of innovative brand and generic CPM products are identified, including: (1) price negotiation, mechanism of new entry of innovative brand CPM products into the national reimbursement list; (2) price re-negotiation, mechanism of price adjustment of innovative brand CPM products within the national reimbursement list; (3) mass procurement, mechanism of generic CPM products to healthcare security system; and (4) direct removal, mechanism of removal from the national reimbursement list. Conclusions China has established market access framework of CPM products by focusing on price negotiation for innovative brand CPM products and mass procurement for generic CPM products. Further studies of CPM products based real-world data are needed to provide clinical and pharmacoeconomic evidence to support market access of CPM products into healthcare security systems.https://doi.org/10.1186/s13020-021-00560-wChinese patent medicineChinese medicineMarket accessHealthcare security systemPrice negotiationPharmacoeconomics |
| spellingShingle | Chenglai Xia Dongning Yao Yunfeng Lai Yan Xue Hao Hu Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems Chinese Medicine Chinese patent medicine Chinese medicine Market access Healthcare security system Price negotiation Pharmacoeconomics |
| title | Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems |
| title_full | Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems |
| title_fullStr | Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems |
| title_full_unstemmed | Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems |
| title_short | Market access of Chinese patent medicine products to healthcare security system in China: implications for international integration of traditional medicine into health systems |
| title_sort | market access of chinese patent medicine products to healthcare security system in china implications for international integration of traditional medicine into health systems |
| topic | Chinese patent medicine Chinese medicine Market access Healthcare security system Price negotiation Pharmacoeconomics |
| url | https://doi.org/10.1186/s13020-021-00560-w |
| work_keys_str_mv | AT chenglaixia marketaccessofchinesepatentmedicineproductstohealthcaresecuritysysteminchinaimplicationsforinternationalintegrationoftraditionalmedicineintohealthsystems AT dongningyao marketaccessofchinesepatentmedicineproductstohealthcaresecuritysysteminchinaimplicationsforinternationalintegrationoftraditionalmedicineintohealthsystems AT yunfenglai marketaccessofchinesepatentmedicineproductstohealthcaresecuritysysteminchinaimplicationsforinternationalintegrationoftraditionalmedicineintohealthsystems AT yanxue marketaccessofchinesepatentmedicineproductstohealthcaresecuritysysteminchinaimplicationsforinternationalintegrationoftraditionalmedicineintohealthsystems AT haohu marketaccessofchinesepatentmedicineproductstohealthcaresecuritysysteminchinaimplicationsforinternationalintegrationoftraditionalmedicineintohealthsystems |